Showing results (61-70 of 631) with videos related to
Sort By:
Pageof 64
Journal of the American College of Cardiology|November 1, 1987
Molecular mechanism of action of newer thrombolytic agentsD CollenThe American Journal of Cardiology|January 3, 1992
Designing thrombolytic agents: focus on safety and efficacyD CollenEuropean Journal of Biochemistry|October 1, 1976
Identification and some properties of a new fast-reacting plasmin inhibitor in human plasmaD CollenBlood|May 11, 1999
Structure-function analyses of thrombomodulin by gene-targeting in mice: the cytoplasmic domain is not required for normal fetal developmentE M Conway, S Pollefeyt, J Cornelissen, et al.The Journal of Clinical Investigation|December 1, 1993
Plasminogen activator inhibitor-1 gene-deficient mice. I. Generation by homologous recombination and characterizationP Carmeliet, L Kieckens, L Schoonjans, et al.The Journal of Clinical Investigation|December 1, 1993
Plasminogen activator inhibitor-1 gene-deficient mice. II. Effects on hemostasis, thrombosis, and thrombolysisP Carmeliet, J M Stassen, L Schoonjans, et al.Nature Genetics|December 17, 1997
Urokinase-generated plasmin activates matrix metalloproteinases during aneurysm formationP Carmeliet, L Moons, R Lijnen, et al.Proceedings of the National Academy of Sciences of the United States of America|June 11, 1996
Urokinase-type plasminogen activator is effective in fibrin clearance in the absence of its receptor or tissue-type plasminogen activatorT H Bugge, M J Flick, M J Danton, et al.Texas Heart Institute Journal|December 1, 1984
Coronary thrombolysis with tissue-type plasminogen activator: prospective reviewD Collen DActa Physiologica (Oxford, England)|June 22, 2011
Paracrine control of vascular innervation in health and diseaseE Storkebaum, P CarmelietPageof 64